Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006279.5(ST3GAL3):c.80C>T(p.Ala27Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A27A) has been classified as Likely benign.
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
Feb 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 27 of the ST3GAL3 protein (p.Ala27Val). This variant is present in population databases (rs751825349, gnomAD 0.0009%). This missense change has been observed in individual(s) with autism (PMID: 35982160). ClinVar contains an entry for this variant (Variation ID: 941994). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);Gain of methylation at K29 (P = 0.0829);.;.;